TNF receptor/IgG1 fusion protein (Anhui Anke Biotechnology)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTNF receptor/IgG1 fusion protein (Anhui Anke Biotechnology)
Drug Alias NameTNF receptor-Fc fusion protein
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionTumor necrosis factor agonists
TargetsTumor necrosis factor
Therapy Area/IndicationsArthritis, RheumatoidSpondylitis, Ankylosing
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesAnhui Anke Biotechnology (Group) Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnhui Anke Biotechnology (Group) Co Ltd
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidSpondylitis, Ankylosing

Other Information

ATC CodeN/A
Related LinksN/A